Muriello Michael J, Viall Sarah, Bottiglieri Teodoro, Cusmano-Ozog Kristina, Ferreira Carlos R
McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Division of Genetics and Metabolism, Children's National Health System, Washington, DC, USA.
Mol Genet Metab Rep. 2017 Jul 15;13:9-12. doi: 10.1016/j.ymgmr.2017.07.004. eCollection 2017 Dec.
Methionine adenosyltransferase (MAT) I/III deficiency is an inborn error of metabolism caused by mutations in , encoding the catalytic subunit of MAT responsible for the synthesis of S-adenosylmethionine, and is characterized by persistent hypermethioninemia. While historically considered a recessive disorder, a milder autosomal dominant form of MAT I/III deficiency occurs, though only the most common mutation p.Arg264His has ample evidence to prove dominant inheritance. We report a case of hypermethioninemia caused by the p.Ala259Val substitution and provide evidence of autosomal dominant inheritance by showing both maternal inheritance of the mutation and concomitant hypermethioninemia. The p.Ala259Val mutation falls in the dimer interface, and thus likely leads to dominant inheritance by a similar mechanism to that described in the previously reported dominant negative mutation, that is, by means of interference with subunits encoded by the wild-type allele.
甲硫氨酸腺苷转移酶(MAT)I/III缺乏症是一种先天性代谢缺陷,由编码负责合成S-腺苷甲硫氨酸的MAT催化亚基的基因突变引起,其特征是持续性高甲硫氨酸血症。虽然历史上认为这是一种隐性疾病,但也存在一种症状较轻的常染色体显性形式的MAT I/III缺乏症,不过只有最常见的p.Arg264His突变有充分证据证明其显性遗传。我们报告了一例由p.Ala259Val替代引起的高甲硫氨酸血症病例,并通过展示该突变的母系遗传以及伴随的高甲硫氨酸血症,提供了常染色体显性遗传的证据。p.Ala259Val突变位于二聚体界面,因此可能通过与先前报道的显性负性突变中所描述的类似机制导致显性遗传,即通过干扰野生型等位基因编码的亚基。